Growth pattern and p53 overexpression in patients with early gastric cancer. 1995

H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

BACKGROUND The growth pattern of early gastric carcinoma, based on a volumetric analysis, reflects well biologic characteristics of the tumor. The penetrating growth (Pen) type tumor has an unfavorable prognosis, compared with a superficially spreading (Super) type. Abnormality of the p53 suppressor gene plays an important role in alteration of cells leading to development of cancer. p53 point mutations are present even in an early stage of carcinoma. METHODS In 159 patients with early gastric carcinoma, overexpression of p53 was studied immunohistochemically, using a monoclonal antibody (PAb 1801), and the relationship between growth pattern and p53 overexpression was analyzed. RESULTS Early gastric carcinoma was grouped into 43 of the Super type, 37 of the expansively penetrating growth (Pen-A) type, 16 of the infiltratively penetrating growth (Pen-B) type, and 63 of the Small mucosal type limited to the mucosal layer. The Pen-A type tumors were characterized by the highest incidence of p53 positive expression and poorest postoperative course. Between the Pen-A type and the Super type, there were significant differences in the incidence of the p53 positive expression (43% vs. 16%), the frequency of recurrence (16% vs. 7%), and disease free interval (574 days vs. 2926 days). CONCLUSIONS The authors' observations show that the p53 gene plays an important role in expansion of gastric carcinoma, even in the early stages.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene

Related Publications

H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
June 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
January 1997, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
May 1999, Orvosi hetilap,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
January 1997, Oncology,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
July 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
August 1996, Gynecologic oncology,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
May 2021, Oncology letters,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
October 2001, Cancer,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
January 2011, Endoscopy,
H Oiwa, and Y Maehara, and S Ohno, and Y Sakaguchi, and Y Ichiyoshi, and K Sugimachi
September 2007, Genetics and molecular research : GMR,
Copied contents to your clipboard!